Bill > HR1414

This bill, known as Cameron's Law, seeks to modify the Internal Revenue Code by increasing the orphan drug tax credit from 25% to 50%. The orphan drug tax credit is a financial incentive designed to encourage pharmaceutical companies to develop medications for rare diseases that might otherwise be economically unviable to research and produce. By raising the tax credit percentage, the bill aims to provide greater financial support and motivation for companies to invest in developing treatments for rare medical conditions. The amendment would apply to all taxable years starting after the date the law is enacted, effectively immediately increasing the tax benefit for pharmaceutical companies engaged in research and development of drugs targeting rare diseases.

Budget and Finance

https://www.congress.gov/bill/119th-congress/house-bill/1414/all-info